The right-handed power hitter with a .528 career average, 130 hits, 33 home runs and 136 RBIs was drawn to the ...

GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart ...

Artificial intelligence (AI) tools are effective for detecting left ventricular systolic dysfunction (LVSD) among women of ...

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the results of a nationwide real-world study, published by Dr. Strom ...

Magnetic resonance imaging (MRI) scans of the heart could help to detect a life-threatening heart disease and enable clinicians to better predict which patients are most at risk, according to a new ...

The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...

New study based on nationwide claims data from more than 11 million patients shows diagnostic CEUS exams are safe and lower ...

Recent prospective randomized controlled trial investigated the impact of transesophageal echocardiography (TEE) probe ...

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication ...